Drug
Norepinephrine (bitartrate)
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Cardiogenic Shock | 667 | 78.8 | 83.0 | signal |
| 2 | Appendicitis | 293 | 52.3 | 53.5 | signal |
| 3 | Multiple Organ Dysfunction Syndrome | 857 | 50.9 | 54.4 | signal |
| 4 | Ventricular Fibrillation | 323 | 48.0 | 49.2 | signal |
| 5 | Shock | 458 | 32.9 | 34.1 | signal |
| 6 | Acute Respiratory Distress Syndrome | 268 | 24.7 | 25.2 | signal |
| 7 | Toxic Epidermal Necrolysis | 220 | 23.8 | 24.2 | signal |
| 8 | Metabolic Acidosis | 419 | 21.6 | 22.2 | signal |
| 9 | Septic Shock | 570 | 21.5 | 22.4 | signal |
| 10 | Ventricular Tachycardia | 196 | 19.2 | 19.5 | signal |
| 11 | Ascites | 337 | 18.6 | 19.1 | signal |
| 12 | Lactic Acidosis | 352 | 17.8 | 18.3 | signal |
| 13 | Bacterial Infection | 189 | 16.5 | 16.7 | signal |
| 14 | Incorrect Route Of Product Administration | 168 | 16.2 | 16.4 | signal |
| 15 | Serotonin Syndrome | 183 | 15.5 | 15.7 | signal |
| 16 | Multi-organ Failure | 161 | 14.9 | 15.1 | signal |
| 17 | Disseminated Intravascular Coagulation | 129 | 14.8 | 14.9 | signal |
| 18 | Circulatory Collapse | 148 | 14.0 | 14.2 | signal |
| 19 | Hyperlipidaemia | 103 | 13.9 | 14.0 | signal |
| 20 | Cardiac Arrest | 661 | 12.9 | 13.6 | signal |
| 21 | Respiratory Depression | 97 | 12.8 | 12.9 | signal |
| 22 | Bradycardia | 374 | 11.4 | 11.7 | signal |
| 23 | Drug Reaction With Eosinophilia And Systemic Symptoms | 179 | 11.3 | 11.5 | signal |
| 24 | Coagulopathy | 116 | 11.3 | 11.4 | signal |
| 25 | End Stage Renal Disease | 128 | 11.2 | 11.3 | signal |
| 26 | Supraventricular Tachycardia | 66 | 11.2 | 11.2 | signal |
| 27 | Renal Tubular Necrosis | 67 | 11.0 | 11.1 | signal |
| 28 | Cardiomyopathy | 100 | 10.9 | 11.0 | signal |
| 29 | Respiratory Failure | 490 | 10.9 | 11.2 | signal |
| 30 | Hyponatraemia | 375 | 10.8 | 11.1 | signal |
| 31 | Aspiration | 72 | 10.7 | 10.8 | signal |
| 32 | Hypotension | 1,303 | 10.5 | 11.6 | signal |
| 33 | Sepsis | 724 | 10.5 | 11.0 | signal |
| 34 | Neuralgia | 157 | 10.5 | 10.6 | signal |
| 35 | Hypoxia | 226 | 10.4 | 10.6 | signal |
| 36 | Hypothermia | 64 | 10.2 | 10.2 | signal |
| 37 | Rhabdomyolysis | 258 | 10.0 | 10.2 | signal |
| 38 | Electrocardiogram Qt Prolonged | 223 | 10.0 | 10.2 | signal |
| 39 | Acute Respiratory Failure | 118 | 10.0 | 10.0 | signal |
| 40 | Sinus Bradycardia | 59 | 9.8 | 9.9 | signal |
| 41 | Intentional Overdose | 387 | 9.8 | 10.1 | signal |
| 42 | Blood Test Abnormal | 85 | 9.8 | 9.8 | signal |
| 43 | Acute Kidney Injury | 899 | 9.5 | 10.2 | signal |
| 44 | Gout | 104 | 9.4 | 9.4 | signal |
| 45 | Ulcer | 92 | 9.3 | 9.4 | signal |
| 46 | Premature Delivery | 92 | 9.3 | 9.4 | signal |
| 47 | Sinus Tachycardia | 80 | 9.1 | 9.2 | signal |
| 48 | Leukocytosis | 100 | 8.9 | 9.0 | signal |
| 49 | Coma | 247 | 8.4 | 8.5 | signal |
| 50 | Cholestasis | 98 | 8.3 | 8.3 | signal |
| 51 | Tachypnoea | 66 | 7.9 | 7.9 | signal |
| 52 | Hyperkalaemia | 170 | 7.9 | 8.0 | signal |
| 53 | Transaminases Increased | 107 | 7.8 | 7.8 | signal |
| 54 | Stress | 345 | 7.7 | 7.9 | signal |
| 55 | Cytokine Release Syndrome | 91 | 7.7 | 7.8 | signal |
| 56 | Drug Ineffective For Unapproved Indication | 266 | 7.7 | 7.8 | signal |
| 57 | Blood Lactate Dehydrogenase Increased | 75 | 7.6 | 7.6 | signal |
| 58 | Brain Oedema | 59 | 7.5 | 7.6 | signal |
| 59 | Anaphylactic Shock | 116 | 7.3 | 7.4 | signal |
| 60 | Premature Baby | 136 | 7.3 | 7.3 | signal |
| 61 | Hepatic Cytolysis | 53 | 7.0 | 7.0 | signal |
| 62 | Bacteraemia | 51 | 7.0 | 7.0 | signal |
| 63 | Toxicity To Various Agents | 726 | 7.0 | 7.3 | signal |
| 64 | Blood Potassium Increased | 68 | 6.8 | 6.8 | signal |
| 65 | Pulmonary Oedema | 187 | 6.7 | 6.8 | signal |
| 66 | Posterior Reversible Encephalopathy Syndrome | 39 | 6.6 | 6.6 | signal |
| 67 | Tachycardia | 364 | 6.6 | 6.8 | signal |
| 68 | Pneumothorax | 64 | 6.5 | 6.5 | signal |
| 69 | Generalised Tonic-clonic Seizure | 66 | 6.5 | 6.5 | signal |
| 70 | Liver Function Test Increased | 86 | 6.5 | 6.5 | signal |
| 71 | Hyperbilirubinaemia | 41 | 6.4 | 6.4 | signal |
| 72 | Encephalopathy | 95 | 6.3 | 6.3 | signal |
| 73 | Candida Infection | 64 | 6.2 | 6.2 | signal |
| 74 | Mydriasis | 49 | 6.2 | 6.2 | signal |
| 75 | Full Blood Count Abnormal | 40 | 6.1 | 6.1 | signal |
| 76 | Micturition Urgency | 43 | 6.1 | 6.1 | signal |
| 77 | Hypercholesterolaemia | 36 | 6.1 | 6.1 | signal |
| 78 | Myoclonus | 44 | 5.9 | 6.0 | signal |
| 79 | Brain Injury | 37 | 5.9 | 6.0 | signal |
| 80 | Hepatic Failure | 111 | 5.9 | 6.0 | signal |
| 81 | Chronic Obstructive Pulmonary Disease | 186 | 5.8 | 5.8 | signal |
| 82 | Blood Cholesterol Increased | 165 | 5.7 | 5.8 | signal |
| 83 | Acute Hepatic Failure | 47 | 5.6 | 5.6 | signal |
| 84 | Status Epilepticus | 39 | 5.6 | 5.6 | signal |
| 85 | Depressed Level Of Consciousness | 136 | 5.6 | 5.6 | signal |
| 86 | Therapy Non-responder | 153 | 5.5 | 5.6 | signal |
| 87 | Cardio-respiratory Arrest | 144 | 5.5 | 5.6 | signal |
| 88 | General Physical Health Deterioration | 393 | 5.5 | 5.7 | signal |
| 89 | Blood Creatinine Increased | 218 | 5.4 | 5.4 | signal |
| 90 | Blood Creatine Phosphokinase Increased | 97 | 5.3 | 5.4 | signal |
| 91 | Myocardial Ischaemia | 38 | 5.3 | 5.3 | signal |
| 92 | Rash Maculo-papular | 73 | 5.3 | 5.3 | signal |
| 93 | Covid-19 Pneumonia | 39 | 5.3 | 5.3 | signal |
| 94 | Ileus | 40 | 5.2 | 5.3 | signal |
| 95 | Product Packaging Issue | 30 | 5.2 | 5.2 | signal |
| 96 | Renal Failure | 432 | 5.2 | 5.3 | signal |
| 97 | Pleural Effusion | 194 | 5.1 | 5.2 | signal |
| 98 | Aspartate Aminotransferase Increased | 169 | 5.1 | 5.2 | signal |
| 99 | Mitral Valve Incompetence | 36 | 5.1 | 5.1 | signal |
| 100 | Alanine Aminotransferase Increased | 195 | 5.1 | 5.2 | signal |
| 101 | Pulmonary Congestion | 42 | 5.1 | 5.1 | signal |
| 102 | Pulmonary Hypertension | 66 | 5.1 | 5.1 | signal |
| 103 | Abdominal Distension | 324 | 5.0 | 5.1 | signal |
| 104 | Respiratory Distress | 86 | 5.0 | 5.0 | signal |
| 105 | Renal Impairment | 260 | 5.0 | 5.1 | signal |
| 106 | Mental Status Changes | 86 | 5.0 | 5.0 | signal |
| 107 | Renal Injury | 91 | 4.9 | 4.9 | signal |
| 108 | Hepatotoxicity | 67 | 4.9 | 4.9 | signal |
| 109 | Pneumonia Aspiration | 75 | 4.8 | 4.9 | signal |
| 110 | Atelectasis | 29 | 4.8 | 4.8 | signal |
| 111 | Fear | 81 | 4.8 | 4.8 | signal |
| 112 | Nephropathy Toxic | 33 | 4.8 | 4.8 | signal |
| 113 | Obstructive Airways Disorder | 33 | 4.8 | 4.8 | signal |
| 114 | Ejection Fraction Decreased | 46 | 4.8 | 4.8 | signal |
| 115 | Thrombocytopenia | 310 | 4.5 | 4.6 | signal |
| 116 | Delirium | 96 | 4.5 | 4.5 | signal |
| 117 | Blood Bilirubin Increased | 75 | 4.5 | 4.5 | signal |
| 118 | Clostridium Difficile Colitis | 29 | 4.4 | 4.4 | signal |
| 119 | Blood Pressure Decreased | 181 | 4.4 | 4.4 | signal |
| 120 | Drug Level Increased | 45 | 4.4 | 4.4 | signal |
| 121 | Condition Aggravated | 819 | 4.4 | 4.6 | signal |
| 122 | Pulmonary Embolism | 258 | 4.4 | 4.4 | signal |
| 123 | Hypotonia | 27 | 4.3 | 4.3 | signal |
| 124 | Ventricular Extrasystoles | 28 | 4.3 | 4.3 | signal |
| 125 | Sputum Discoloured | 25 | 4.3 | 4.3 | signal |
| 126 | Altered State Of Consciousness | 56 | 4.2 | 4.2 | signal |
| 127 | Emphysema | 26 | 4.1 | 4.1 | signal |
| 128 | Renal Failure Acute | 110 | 4.1 | 4.1 | signal |
| 129 | Diabetes Mellitus | 194 | 4.1 | 4.1 | signal |
| 130 | Nervous System Disorder | 79 | 4.1 | 4.1 | signal |
| 131 | Thrombosis | 203 | 4.1 | 4.1 | signal |
| 132 | Hypokalaemia | 115 | 4.0 | 4.1 | signal |
| 133 | Intentional Product Misuse | 217 | 4.0 | 4.1 | signal |
| 134 | Unresponsive To Stimuli | 64 | 4.0 | 4.0 | signal |
| 135 | Drug Interaction | 392 | 4.0 | 4.1 | signal |
| 136 | Cardiovascular Disorder | 63 | 4.0 | 4.0 | signal |
| 137 | Eosinophilia | 43 | 4.0 | 4.0 | signal |
| 138 | Stevens-johnson Syndrome | 54 | 3.9 | 3.9 | signal |
| 139 | Adverse Reaction | 32 | 3.9 | 3.9 | signal |
| 140 | Blood Urea Increased | 40 | 3.8 | 3.8 | signal |
| 141 | Dry Mouth | 191 | 3.8 | 3.8 | signal |
| 142 | Haemoptysis | 63 | 3.6 | 3.6 | signal |
| 143 | Upper Gastrointestinal Haemorrhage | 38 | 3.6 | 3.6 | signal |
| 144 | Subarachnoid Haemorrhage | 23 | 3.6 | 3.6 | signal |
| 145 | Foetal Exposure During Pregnancy | 181 | 3.6 | 3.6 | signal |
| 146 | Post Procedural Haemorrhage | 26 | 3.6 | 3.6 | signal |
| 147 | Anaphylactic Reaction | 122 | 3.6 | 3.6 | signal |
| 148 | Pneumocystis Jirovecii Pneumonia | 22 | 3.5 | 3.5 | signal |
| 149 | Drug Ineffective | 2,882 | 3.5 | 4.2 | signal |
| 150 | Suicide Attempt | 133 | 3.5 | 3.5 | signal |
| 151 | Electrolyte Imbalance | 25 | 3.5 | 3.5 | signal |
| 152 | Adrenal Insufficiency | 26 | 3.5 | 3.5 | signal |
| 153 | Urosepsis | 20 | 3.5 | 3.5 | signal |
| 154 | Joint Injury | 46 | 3.5 | 3.5 | signal |
| 155 | Generalised Oedema | 26 | 3.4 | 3.4 | signal |
| 156 | Hypercalcaemia | 26 | 3.4 | 3.4 | signal |
| 157 | Hyperglycaemia | 76 | 3.4 | 3.4 | signal |
| 158 | Anhedonia | 55 | 3.3 | 3.4 | signal |
| 159 | Hypocalcaemia | 39 | 3.3 | 3.3 | signal |
| 160 | Coronary Artery Disease | 63 | 3.3 | 3.3 | signal |
| 161 | Hypoglycaemia | 100 | 3.3 | 3.3 | signal |
| 162 | Dialysis | 29 | 3.3 | 3.3 | signal |
| 163 | Sleep Disorder | 140 | 3.2 | 3.2 | signal |
| 164 | Hepatic Function Abnormal | 74 | 3.2 | 3.2 | signal |
| 165 | Staphylococcal Infection | 65 | 3.2 | 3.2 | signal |
| 166 | Pericardial Effusion | 44 | 3.1 | 3.1 | signal |
| 167 | Liver Injury | 46 | 3.1 | 3.1 | signal |
| 168 | Lower Respiratory Tract Infection | 86 | 3.1 | 3.1 | signal |
| 169 | Face Oedema | 32 | 3.0 | 3.0 | signal |
| 170 | Exposure During Pregnancy | 117 | 3.0 | 3.0 | signal |
| 171 | Anaemia | 357 | 3.0 | 3.1 | signal |
| 172 | Product Administration Error | 37 | 3.0 | 3.0 | signal |
| 173 | Drug Intolerance | 178 | 3.0 | 3.0 | signal |
| 174 | Swelling | 172 | 3.0 | 3.0 | signal |
| 175 | Maternal Exposure During Pregnancy | 160 | 2.9 | 2.9 | signal |
| 176 | Febrile Neutropenia | 120 | 2.9 | 2.9 | signal |
| 177 | Haemorrhage Intracranial | 27 | 2.9 | 2.9 | signal |
| 178 | Agranulocytosis | 33 | 2.9 | 2.9 | signal |
| 179 | Pulmonary Arterial Hypertension | 26 | 2.9 | 2.9 | signal |
| 180 | Toxic Skin Eruption | 18 | 2.9 | 2.9 | signal |
| 181 | Cardiac Failure | 143 | 2.9 | 2.9 | signal |
| 182 | Fluid Overload | 26 | 2.8 | 2.8 | signal |
| 183 | Clostridium Difficile Infection | 38 | 2.8 | 2.8 | signal |
| 184 | Drug Resistance | 45 | 2.8 | 2.8 | signal |
| 185 | Pulmonary Mass | 26 | 2.8 | 2.8 | signal |
| 186 | Neurotoxicity | 30 | 2.8 | 2.8 | signal |
| 187 | Accidental Overdose | 63 | 2.8 | 2.8 | signal |
| 188 | Hypokinesia | 25 | 2.8 | 2.8 | signal |
| 189 | Overdose | 372 | 2.8 | 2.8 | signal |
| 190 | Cyanosis | 27 | 2.8 | 2.8 | signal |
| 191 | Jaundice | 46 | 2.7 | 2.7 | signal |
| 192 | Peritonitis | 35 | 2.7 | 2.7 | signal |
| 193 | Conjunctivitis | 31 | 2.7 | 2.7 | signal |
| 194 | Injection Site Extravasation | 21 | 2.7 | 2.7 | signal |
| 195 | Motor Dysfunction | 17 | 2.7 | 2.7 | signal |
| 196 | Myocarditis | 19 | 2.7 | 2.7 | signal |
| 197 | Cerebral Infarction | 41 | 2.7 | 2.7 | signal |
| 198 | Pulmonary Fibrosis | 32 | 2.7 | 2.7 | signal |
| 199 | Abdominal Pain | 387 | 2.7 | 2.7 | signal |
| 200 | Atrial Fibrillation | 162 | 2.7 | 2.7 | signal |
| 201 | Product Use In Unapproved Indication | 405 | 2.7 | 2.7 | signal |
| 202 | International Normalised Ratio Increased | 47 | 2.6 | 2.6 | signal |
| 203 | Liver Disorder | 72 | 2.6 | 2.6 | signal |
| 204 | Upper Respiratory Tract Infection | 75 | 2.6 | 2.6 | signal |
| 205 | Acute Myocardial Infarction | 48 | 2.6 | 2.6 | signal |
| 206 | Transfusion | 17 | 2.6 | 2.6 | signal |
| 207 | Abortion Induced | 15 | 2.6 | 2.6 | signal |
| 208 | Arrhythmia | 75 | 2.5 | 2.5 | signal |
| 209 | Hypophagia | 40 | 2.5 | 2.5 | signal |
| 210 | Haematoma | 41 | 2.5 | 2.5 | signal |
| 211 | Drug Level Decreased | 16 | 2.5 | 2.5 | signal |
| 212 | Off Label Use | 1,348 | 2.5 | 2.7 | signal |
| 213 | Blood Alkaline Phosphatase Increased | 38 | 2.5 | 2.5 | signal |
| 214 | Intestinal Perforation | 17 | 2.4 | 2.4 | signal |
| 215 | Muscle Rigidity | 18 | 2.4 | 2.4 | signal |
| 216 | Cytomegalovirus Infection | 25 | 2.4 | 2.4 | signal |
| 217 | Lymphopenia | 21 | 2.4 | 2.4 | signal |
| 218 | Pancytopenia | 82 | 2.4 | 2.4 | signal |
| 219 | Somnolence | 295 | 2.4 | 2.4 | signal |
| 220 | Lung Disorder | 71 | 2.3 | 2.3 | signal |
| 221 | Leukopenia | 72 | 2.3 | 2.3 | signal |
| 222 | Constipation | 311 | 2.3 | 2.3 | signal |
| 223 | Hypertensive Crisis | 16 | 2.3 | 2.3 | signal |
| 224 | Neuroleptic Malignant Syndrome | 17 | 2.3 | 2.3 | signal |
| 225 | Chromaturia | 32 | 2.3 | 2.3 | signal |
| 226 | Injury | 100 | 2.3 | 2.3 | signal |
| 227 | Pancreatitis Acute | 31 | 2.2 | 2.2 | signal |
| 228 | Transient Ischaemic Attack | 47 | 2.2 | 2.2 | signal |
| 229 | Post Procedural Complication | 26 | 2.2 | 2.2 | signal |
| 230 | Malnutrition | 15 | 2.2 | 2.2 | signal |
| 231 | Hepatocellular Injury | 19 | 2.1 | 2.2 | signal |
| 232 | Bronchospasm | 19 | 2.1 | 2.1 | signal |
| 233 | Paralysis | 19 | 2.1 | 2.1 | signal |
| 234 | Glomerular Filtration Rate Decreased | 16 | 2.1 | 2.1 | signal |
| 235 | C-reactive Protein Increased | 48 | 2.1 | 2.1 | signal |
| 236 | Haematocrit Decreased | 26 | 2.1 | 2.1 | signal |
| 237 | Mouth Ulceration | 27 | 2.1 | 2.1 | signal |
| 238 | Unevaluable Event | 97 | 2.1 | 2.1 | signal |
| 239 | Platelet Count Decreased | 136 | 2.1 | 2.1 | signal |
| 240 | Pneumonia | 412 | 2.1 | 2.1 | signal |
| 241 | Seizure | 146 | 2.0 | 2.1 | signal |
| 242 | Body Temperature Increased | 26 | 2.0 | 2.0 | signal |
| 243 | Agitation | 93 | 2.0 | 2.0 | signal |
| 244 | Subdural Haematoma | 18 | 2.0 | 2.0 | signal |
| 245 | Gingival Bleeding | 17 | 2.0 | 2.0 | no signal |
| 246 | Rebound Effect | 14 | 2.0 | 2.0 | no signal |
| 247 | Blister | 69 | 2.0 | 2.0 | no signal |
| 248 | Cerebral Haemorrhage | 44 | 2.0 | 2.0 | no signal |
| 249 | Product Prescribing Issue | 25 | 2.0 | 2.0 | no signal |
| 250 | Hypomagnesaemia | 17 | 2.0 | 2.0 | no signal |
| 251 | Pneumonitis | 33 | 2.0 | 2.0 | no signal |
| 252 | Gamma-glutamyltransferase Increased | 27 | 2.0 | 2.0 | no signal |
| 253 | Hepatomegaly | 12 | 2.0 | 2.0 | no signal |
| 254 | Haemorrhage | 127 | 2.0 | 2.0 | no signal |
| 255 | Cardiomegaly | 15 | 1.9 | 1.9 | no signal |
| 256 | Drug Hypersensitivity | 230 | 1.9 | 1.9 | no signal |
| 257 | Inappropriate Antidiuretic Hormone Secretion | 12 | 1.9 | 1.9 | no signal |
| 258 | Melaena | 26 | 1.9 | 1.9 | no signal |
| 259 | Gastrointestinal Haemorrhage | 98 | 1.9 | 1.9 | no signal |
| 260 | Liver Function Test Abnormal | 34 | 1.9 | 1.9 | no signal |
| 261 | Oxygen Saturation Decreased | 64 | 1.8 | 1.8 | no signal |
| 262 | Small Intestinal Obstruction | 14 | 1.8 | 1.8 | no signal |
| 263 | Respiratory Disorder | 34 | 1.8 | 1.8 | no signal |
| 264 | Hypertension | 240 | 1.8 | 1.8 | no signal |
| 265 | Neutrophil Count Decreased | 45 | 1.8 | 1.8 | no signal |
| 266 | Oedema | 59 | 1.8 | 1.8 | no signal |
| 267 | Iron Deficiency Anaemia | 10 | 1.8 | 1.8 | no signal |
| 268 | Lung Infection | 17 | 1.7 | 1.7 | no signal |
| 269 | Lymphocyte Count Decreased | 19 | 1.7 | 1.7 | no signal |
| 270 | Hepatic Encephalopathy | 10 | 1.7 | 1.7 | no signal |
| 271 | Ischaemic Stroke | 19 | 1.7 | 1.7 | no signal |
| 272 | Oedema Peripheral | 129 | 1.7 | 1.7 | no signal |
| 273 | Device Failure | 16 | 1.7 | 1.7 | no signal |
| 274 | Spinal Pain | 12 | 1.6 | 1.6 | no signal |
| 275 | Peripheral Coldness | 14 | 1.6 | 1.6 | no signal |
| 276 | Hepatitis | 26 | 1.6 | 1.6 | no signal |
| 277 | Cholecystitis | 12 | 1.6 | 1.6 | no signal |
| 278 | Polyneuropathy | 12 | 1.6 | 1.6 | no signal |
| 279 | Gastric Ulcer | 19 | 1.6 | 1.6 | no signal |
| 280 | Medication Error | 54 | 1.6 | 1.6 | no signal |
| 281 | Pyrexia | 335 | 1.6 | 1.6 | no signal |
| 282 | Erythema Multiforme | 9 | 1.6 | 1.6 | no signal |
| 283 | Deep Vein Thrombosis | 63 | 1.6 | 1.6 | no signal |
| 284 | Diabetic Ketoacidosis | 23 | 1.5 | 1.5 | no signal |
| 285 | Lethargy | 55 | 1.5 | 1.5 | no signal |
| 286 | Arteriosclerosis | 9 | 1.5 | 1.5 | no signal |
| 287 | Haemoglobin Decreased | 97 | 1.5 | 1.5 | no signal |
| 288 | Drug-induced Liver Injury | 29 | 1.5 | 1.5 | no signal |
| 289 | Vomiting | 438 | 1.5 | 1.5 | no signal |
| 290 | Colitis | 35 | 1.5 | 1.5 | no signal |
| 291 | Musculoskeletal Stiffness | 80 | 1.5 | 1.5 | no signal |
| 292 | Drug Eruption | 16 | 1.5 | 1.5 | no signal |
| 293 | Treatment Failure | 74 | 1.4 | 1.5 | no signal |
| 294 | Neutrophil Count Increased | 9 | 1.4 | 1.4 | no signal |
| 295 | Haematemesis | 22 | 1.4 | 1.4 | no signal |
| 296 | Angioedema | 38 | 1.4 | 1.4 | no signal |
| 297 | Blood Pressure Abnormal | 17 | 1.4 | 1.4 | no signal |
| 298 | White Blood Cell Count Increased | 33 | 1.4 | 1.4 | no signal |
| 299 | Neutropenia | 116 | 1.4 | 1.4 | no signal |
| 300 | Pallor | 23 | 1.4 | 1.4 | no signal |
| 301 | Device Related Infection | 13 | 1.4 | 1.4 | no signal |
| 302 | Chronic Kidney Disease | 64 | 1.3 | 1.3 | no signal |
| 303 | Disease Progression | 97 | 1.3 | 1.3 | no signal |
| 304 | Therapy Partial Responder | 12 | 1.3 | 1.3 | no signal |
| 305 | Pancreatitis | 40 | 1.2 | 1.2 | no signal |
| 306 | Fungal Infection | 25 | 1.2 | 1.2 | no signal |
| 307 | Tubulointerstitial Nephritis | 14 | 1.2 | 1.2 | no signal |
| 308 | Hepatic Enzyme Increased | 50 | 1.2 | 1.2 | no signal |
| 309 | Bone Marrow Failure | 15 | 1.2 | 1.2 | no signal |
| 310 | Haematuria | 25 | 1.2 | 1.2 | no signal |
| 311 | No Therapeutic Response | 9 | 1.2 | 1.2 | no signal |
| 312 | Thrombotic Microangiopathy | 7 | 1.2 | 1.2 | no signal |
| 313 | Respiratory Arrest | 20 | 1.2 | 1.2 | no signal |
| 314 | Loss Of Consciousness | 91 | 1.1 | 1.1 | no signal |
| 315 | Hemiparesis | 12 | 1.1 | 1.1 | no signal |
| 316 | Skin Discolouration | 32 | 1.1 | 1.1 | no signal |
| 317 | Epistaxis | 52 | 1.1 | 1.1 | no signal |
| 318 | Oral Candidiasis | 9 | 1.1 | 1.1 | no signal |
| 319 | Skin Disorder | 23 | 1.1 | 1.1 | no signal |
| 320 | Gastric Haemorrhage | 8 | 1.1 | 1.1 | no signal |
| 321 | Obesity | 11 | 1.1 | 1.1 | no signal |
| 322 | Gastroenteritis | 10 | 1.1 | 1.1 | no signal |
| 323 | Vasculitis | 8 | 1.1 | 1.1 | no signal |
| 324 | Sars-cov-2 Test Positive | 9 | 1.1 | 1.1 | no signal |
| 325 | Petechiae | 7 | 1.1 | 1.1 | no signal |
| 326 | Weight Fluctuation | 7 | 1.1 | 1.1 | no signal |
| 327 | Cytopenia | 8 | 1.1 | 1.1 | no signal |
| 328 | Drug Withdrawal Syndrome Neonatal | 10 | 1.1 | 1.1 | no signal |
| 329 | Contraindicated Product Administered | 20 | 1.1 | 1.1 | no signal |
| 330 | Incontinence | 7 | 1.1 | 1.1 | no signal |
| 331 | Device Occlusion | 9 | 1.0 | 1.0 | no signal |
| 332 | Acute Myeloid Leukaemia | 10 | 1.0 | 1.0 | no signal |
| 333 | Dermatitis Allergic | 8 | 1.0 | 1.0 | no signal |
| 334 | Disease Recurrence | 30 | 1.0 | 1.0 | no signal |
| 335 | Therapy Change | 6 | 1.0 | 1.0 | no signal |
| 336 | Blood Triglycerides Increased | 11 | 1.0 | 1.0 | no signal |
| 337 | Blood Calcium Decreased | 7 | 1.0 | 1.0 | no signal |
| 338 | Cardiac Failure Congestive | 50 | 1.0 | 1.0 | no signal |
| 339 | Heart Rate Increased | 61 | 1.0 | 1.0 | no signal |
| 340 | Platelet Count Increased | 8 | 1.0 | 1.0 | no signal |
| 341 | Dyspnoea | 340 | 1.0 | 1.0 | no signal |
| 342 | Gastrointestinal Disorder | 53 | 1.0 | 1.0 | no signal |
| 343 | Splenomegaly | 7 | 1.0 | 1.0 | no signal |
| 344 | Rash Erythematous | 28 | 1.0 | 1.0 | no signal |
| 345 | Caesarean Section | 7 | 1.0 | 1.0 | no signal |
| 346 | Myelosuppression | 20 | 0.9 | 0.9 | no signal |
| 347 | Ataxia | 7 | 0.9 | 0.9 | no signal |
| 348 | Drug Dispensing Error | 9 | 0.9 | 0.9 | no signal |
| 349 | Asthma | 65 | 0.9 | 0.9 | no signal |
| 350 | Drug Toxicity | 8 | 0.9 | 0.9 | no signal |
| 351 | Heart Rate Decreased | 20 | 0.9 | 0.9 | no signal |
| 352 | Oral Herpes | 11 | 0.9 | 0.9 | no signal |
| 353 | Blood Potassium Decreased | 17 | 0.9 | 0.9 | no signal |
| 354 | Epilepsy | 17 | 0.9 | 0.9 | no signal |
| 355 | Drug Effective For Unapproved Indication | 16 | 0.9 | 0.9 | no signal |
| 356 | Emotional Distress | 66 | 0.9 | 0.9 | no signal |
| 357 | Immunodeficiency | 8 | 0.9 | 0.9 | no signal |
| 358 | Interstitial Lung Disease | 26 | 0.9 | 0.9 | no signal |
| 359 | Cellulitis | 27 | 0.9 | 0.9 | no signal |
| 360 | Grand Mal Convulsion | 5 | 0.9 | 0.9 | no signal |
| 361 | Covid-19 | 94 | 0.9 | 0.9 | no signal |
| 362 | Complication Associated With Device | 7 | 0.9 | 0.9 | no signal |
| 363 | Death | 454 | 0.8 | 0.8 | no signal |
| 364 | Rash Macular | 18 | 0.8 | 0.8 | no signal |
| 365 | Cognitive Disorder | 24 | 0.8 | 0.8 | no signal |
| 366 | No Adverse Event | 91 | 0.8 | 0.8 | no signal |
| 367 | Nausea | 403 | 0.8 | 0.8 | no signal |
| 368 | Coronary Artery Occlusion | 7 | 0.8 | 0.8 | no signal |
| 369 | Wheezing | 30 | 0.8 | 0.8 | no signal |
| 370 | Inflammation | 26 | 0.8 | 0.8 | no signal |
| 371 | Tremor | 84 | 0.8 | 0.8 | no signal |
| 372 | Abscess | 8 | 0.8 | 0.8 | no signal |
| 373 | Mucosal Inflammation | 13 | 0.8 | 0.8 | no signal |
| 374 | Coordination Abnormal | 7 | 0.8 | 0.8 | no signal |
| 375 | Flatulence | 28 | 0.8 | 0.8 | no signal |
| 376 | Folliculitis | 5 | 0.8 | 0.8 | no signal |
| 377 | Product Preparation Error | 10 | 0.8 | 0.8 | no signal |
| 378 | Intestinal Obstruction | 18 | 0.8 | 0.8 | no signal |
| 379 | Intentional Product Use Issue | 42 | 0.8 | 0.8 | no signal |
| 380 | Circumstance Or Information Capable Of Leading To Medication Error | 16 | 0.8 | 0.8 | no signal |
| 381 | Poisoning | 6 | 0.8 | 0.8 | no signal |
| 382 | Restlessness | 17 | 0.7 | 0.7 | no signal |
| 383 | Completed Suicide | 38 | 0.7 | 0.7 | no signal |
| 384 | Emotional Disorder | 14 | 0.7 | 0.7 | no signal |
| 385 | Haematotoxicity | 4 | 0.7 | 0.7 | no signal |
| 386 | Convulsion | 25 | 0.7 | 0.7 | no signal |
| 387 | Diarrhoea Haemorrhagic | 4 | 0.7 | 0.7 | no signal |
| 388 | Leukaemia | 4 | 0.7 | 0.7 | no signal |
| 389 | Psychomotor Hyperactivity | 7 | 0.7 | 0.7 | no signal |
| 390 | Hyperthyroidism | 6 | 0.7 | 0.7 | no signal |
| 391 | Myelodysplastic Syndrome | 6 | 0.7 | 0.7 | no signal |
| 392 | Muscle Spasticity | 5 | 0.6 | 0.6 | no signal |
| 393 | White Blood Cell Count Decreased | 43 | 0.6 | 0.6 | no signal |
| 394 | Product Use Issue | 74 | 0.6 | 0.6 | no signal |
| 395 | Skin Exfoliation | 32 | 0.6 | 0.6 | no signal |
| 396 | Drug Abuse | 32 | 0.6 | 0.6 | no signal |
| 397 | Cerebrovascular Accident | 65 | 0.6 | 0.6 | no signal |
| 398 | Withdrawal Syndrome | 16 | 0.6 | 0.6 | no signal |
| 399 | Sudden Death | 4 | 0.6 | 0.6 | no signal |
| 400 | Blindness | 15 | 0.6 | 0.6 | no signal |
| 401 | Product Dispensing Error | 8 | 0.6 | 0.6 | no signal |
| 402 | Product Prescribing Error | 8 | 0.5 | 0.5 | no signal |
| 403 | Therapeutic Response Decreased | 20 | 0.5 | 0.5 | no signal |
| 404 | Myocardial Infarction | 58 | 0.5 | 0.5 | no signal |
| 405 | Poisoning Deliberate | 3 | 0.5 | 0.5 | no signal |
| 406 | Systemic Lupus Erythematosus | 11 | 0.5 | 0.5 | no signal |
| 407 | Sedation | 8 | 0.5 | 0.5 | no signal |
| 408 | Peritonitis Bacterial | 3 | 0.5 | 0.5 | no signal |
| 409 | Therapy Cessation | 15 | 0.5 | 0.5 | no signal |
| 410 | Drug Administration Error | 9 | 0.5 | 0.5 | no signal |
| 411 | Incorrect Dose Administered | 63 | 0.5 | 0.4 | no signal |
| 412 | Extra Dose Administered | 11 | 0.4 | 0.4 | no signal |
| 413 | Underdose | 19 | 0.4 | 0.4 | no signal |
| 414 | Aggression | 13 | 0.4 | 0.4 | no signal |
| 415 | Hepatitis C | 3 | 0.4 | 0.4 | no signal |
| 416 | Amenorrhoea | 4 | 0.4 | 0.4 | no signal |
| 417 | Device Malfunction | 16 | 0.4 | 0.4 | no signal |
| 418 | Tuberculosis | 3 | 0.4 | 0.4 | no signal |
| 419 | Anorexia | 3 | 0.4 | 0.4 | no signal |
| 420 | Akathisia | 3 | 0.4 | 0.4 | no signal |
| 421 | Accidental Exposure To Product | 21 | 0.3 | 0.3 | no signal |
| 422 | Drug Prescribing Error | 4 | 0.3 | 0.3 | no signal |
| 423 | Drug Withdrawal Syndrome | 18 | 0.3 | 0.3 | no signal |
| 424 | Device Delivery System Issue | 5 | 0.3 | 0.3 | no signal |
| 425 | Tardive Dyskinesia | 5 | 0.3 | 0.3 | no signal |
| 426 | Device Issue | 14 | 0.3 | 0.3 | no signal |
| 427 | Pharmaceutical Product Complaint | 4 | 0.2 | 0.2 | no signal |
| 428 | Device Use Error | 5 | 0.2 | 0.2 | no signal |
| 429 | Incorrect Route Of Drug Administration | 5 | 0.2 | 0.2 | no signal |
| 430 | Wrong Technique In Device Usage Process | 6 | 0.2 | 0.2 | no signal |
| 431 | Drug Dose Omission By Device | 10 | 0.2 | 0.2 | no signal |
| 432 | Incorrect Dose Administered By Device | 3 | 0.2 | 0.2 | no signal |
| 433 | Device Leakage | 4 | 0.2 | 0.2 | no signal |
| 434 | Dependence | 4 | 0.1 | 0.1 | no signal |
| 435 | Drug Dependence | 8 | 0.1 | 0.1 | no signal |